UPDATE: Baird Starts MiNK Therapeutics (INKT) at Outperform
Tweet Send to a Friend
(Updated - November 9, 2021 6:21 AM EST)
Baird analyst Jack Allen initiates coverage on MiNK Therapeutics (NASDAQ: INKT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Jack Allen initiates coverage on MiNK Therapeutics (NASDAQ: INKT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
